Pitfalls in measuring plasma cholesterol in the Smith-Lemli-Opitz syndrome.

Correct quantitative results for plasma cholesterol, 7-dehydrocholesterol (7-DHC), and 8-dehydrocholesterol (8-DHC) are invaluable for making the correct diagnosis in patients with the Smith-Lemli-Opitz syndrome (SLO) and for biochemical monitoring of these patients during therapy. The enzymatic method for cholesterol measurement based on cholesterol oxidase gives falsely high values for plasma cholesterol in samples from patients with SLO. Both 7-DHC and 8-DHC contribute substantially to the test result, given that they are accepted substrates of cholesterol oxidase. All cholesterol methods making use of this enzyme are expected to give unreliable results with plasma samples from SLO patients. Cholesterol values found with these methods may be low-normal in individual cases with SLO. Therefore, other techniques for measuring cholesterol, 7-DHC, and 8-DHC, e.g., gas chromatography, should be used for diagnosing these patients and for follow-up during therapy. However, a normal value for plasma cholesterol, as obtained by gas chromatography, does not exclude SLO. The diagnosis should always be confirmed or excluded by testing for the presence of high concentrations of 7-DHC and 8-DHC in plasma. We found that one patient with a severe form of the disease had a plasma cholesterol concentration of 20 micromol/L-to our knowledge, the lowest value ever recorded in a human being.

[1]  A. Honda,et al.  Markedly inhibited 7-dehydrocholesterol-delta 7-reductase activity in liver microsomes from Smith-Lemli-Opitz homozygotes. , 1995, The Journal of clinical investigation.

[2]  V. P. Johnson,et al.  Correlation of severity and outcome with plasma sterol levels in variants of the Smith-Lemli-Opitz syndrome. , 1995, The Journal of pediatrics.

[3]  K. Mills,et al.  Prenatal diagnosis of Smith-Lemli-Opitz syndrome. , 1995, American journal of medical genetics.

[4]  G. Tint,et al.  Identification of 8-dehydrocholesterol (cholesta-5,8-dien-3 beta-ol) in patients with Smith-Lemli-Opitz syndrome. , 1995, Journal of lipid research.

[5]  K. Mills,et al.  Radon exposure and lung cancer. , 1994 .

[6]  Chatterton Ht Radon exposure and lung cancer. , 1994, The New England journal of medicine.

[7]  J. Opitz,et al.  RSH/SLO ("Smith-Lemli-Opitz") syndrome: historical, genetic, and developmental considerations. , 1994, American journal of medical genetics.

[8]  C. Comstock,et al.  Prenatal diagnosis of Smith-Lemli-Opitz syndrome, type II. , 1994, American journal of medical genetics.

[9]  G Salen,et al.  Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome. , 1994, The New England journal of medicine.

[10]  G. Tint,et al.  Defective cholesterol biosynthesis in Smith-Lemli-Opitz syndrome , 1993, The Lancet.

[11]  J. Fairbank Spinal fusion for low back pain , 1993, The Lancet.

[12]  J. Slotte Substrate specificity of cholesterol oxidase from Streptomyces cinnamomeus—A monolayer study , 1992, The Journal of Steroid Biochemistry and Molecular Biology.

[13]  M. Axelson Occurrence of isomeric dehydrocholesterols in human plasma. , 1991, Journal of lipid research.

[14]  G. Lockitch,et al.  Age- and sex-specific pediatric reference intervals for biochemistry analytes as measured with the Ektachem-700 analyzer. , 1988, Clinical chemistry.

[15]  W. Mcconathy,et al.  Changes in the Serum Lipids and Apolipoproteins in the First Four Weeks of Life , 1986, Pediatric Research.

[16]  K. Taysi,et al.  Possible abnormalities of steroid secretion in children with Smith-Lemli-Opitz syndrome and their parents , 1985, Steroids.

[17]  J. Opitz,et al.  A NEWLY RECOGNIZED SYNDROME OF MULTIPLE CONGENITAL ANOMALIES. , 1964, The Journal of pediatrics.

[18]  K. Mills,et al.  Diagnosis of Smith-Lemli-Opitz syndrome. , 1994, The New England journal of medicine.

[19]  K. Mills,et al.  DIAGNOSIS OF SMITH-LEMLI-OPITZ SYNDROME. AUTHORS' REPLY , 1994 .

[20]  W. Bablok,et al.  A New Biometrical Procedure for Testing the Equality of Measurements from Two Different Analytical Methods. Application of linear regression procedures for method comparison studies in Clinical Chemistry, Part I , 1983, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.